BeStock  
Stocks › Biotechnology › BMRN

Biomarin Pharmaceutical BMRN

US equityMarket cap rank #1288Biotechnology
$60.41 −$1.01 (-1.64%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.02 -0.65%
Open$61.53
Prev close$61.42
Day range$59.84 – $62.01
Volume6.06M
Market cap$11.70B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts23
Average target$88.73+46.9% vs. price
  • Buy 74%
  • Hold 26%
Low $60.00Now $60.41Avg $88.73High $120.00

Recent rating changes

The last 20 actions on file set price targets from $60.00 to $122.00, averaging $91.85.

DateFirmRatingTarget
13 Nov 2026 Morgan Stanley BUY $103.00
13 Nov 2026 Evercore BUY $120.00
4 Nov 2026 H.C. Wainwright HOLD $60.00
4 Nov 2026 Barclays BUY $114.00
4 Nov 2026 J.P. Morgan BUY $86.00
3 Nov 2026 TD Cowen BUY $120.00
3 Nov 2026 Wells Fargo BUY $80.00
3 Nov 2026 UBS BUY $88.00
3 Nov 2026 Wedbush BUY $89.00
3 Nov 2026 Morgan Stanley BUY $119.00
3 Nov 2026 Stifel HOLD $66.00
3 Nov 2026 H.C. Wainwright HOLD $60.00
3 Nov 2026 Oppenheimer BUY $94.00
2 Nov 2026 Cantor Fitzgerald BUY $86.00
2 Nov 2026 BofA Securities BUY $83.00
2 Nov 2026 Morgan Stanley BUY $122.00
2 Nov 2026 BMO Capital BUY $97.00
2 Nov 2026 Citi BUY $76.00
2 Nov 2026 RBC Capital HOLD $60.00
29 Oct 2026 CCORF BUY $114.00

Discussion

No comments yet — be the first to weigh in on BMRN.

Sign in to join the discussion.

Scroll to Top